Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women

NCT06970405 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Obesity

Interventions

DRUG: Garetosmab
DRUG: Matching Placebo

Sponsor

Regeneron Pharmaceuticals